Complicated course of measles among militaries

oleh: V.I. Trykhlib, A.P. Pasiuk, A.S. Tarapovska, N.A. Bokhanova

Format: Article
Diterbitkan: Zaslavsky O.Yu. 2020-11-01

Deskripsi

Background. Currently, measles remains a common disease worldwide and one of the most frequent causes of death among infectious diseases controlled by vaccine prophylaxis agents. The disease develops with different complications, varieties and percentage of them differ in different ca-tegories of people and in countries of the world. The purpose of the study: to investigate the structure of measles complications in military personnel during the last measles epidemic in Ukraine. Materials and methods. To study the structure of measles complications in military personnel during the last epidemic in Ukraine, 120 medical records of patients with measles with complicated course, who were on inpatient treatment at the Clinic of Infectious Diseases of the National Military Medical Clinical Center “Main Military Clinical Hospital” (NMMCC “MMCH”), were analyzed for the period from 01.01.2018 to 31.12.2018. Results. The article analyzed the structure of measles complications in militaries of the Armed Forces of Ukraine, who were admitted to the Clinic of Infectious Diseases of the NMMCC “MMCH” from 01.01.2018 to 31.12.2018. Hepatitis, pancreatitis and pneumonia prevailed in the structure of measles complications among the military personnel. The data on the period of detection of complications from the day of illness and hospitalization are presented. Conclusions. Among servicemen with measles, one complication was identified most often (55 %), while a combination of two complications was registered in 29.2 % of patients, three — in 12.5 %, and four — in 3.3 %. Most common measles complications among military personnel treated in 2018 were as follows: hepatitis (57.5 %), pancreatitis (44.2 %), pneumonia (19.2 %), eye damage (14.2 %), bronchitis (9.2 %), sinusitis (9.2 %) and myocarditis (6.7 %). Complications in measles militaries were most frequently identified on days 4–9 from the beginning of the disease: 12.7 % of patients had complications on day 4, 9.9 % — on day 5, 17.7 % — on day 6, and 12.7 % — on day 7.